Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

To Treat or Not to Treat—Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic

To Treat or Not to Treat—Balancing Benefits and Risks of Treatment Delay Among Patients With... Opinion EDITORIAL To Treat or Not to Treat—Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic Elizabeth Garrett-Mayer, PhD; Brian I. Rini, MD Decisions regarding the initiation of cancer therapy have be- a reluctant patient understand the increased risks of delaying come increasingly complex in the era of coronavirus disease treatment and, vice versa, the estimates may help another pa- 2019 (COVID-19). Health care professionals and patients must tient understand that the risks of cancer treatment delay are balance the benefits and risks of immediate treatment for can- minimal, and the patient can safely delay treatment until in- cer with the potential subse- fection levels in their region have decreased. In other words, quent increases in the risk of the OncCOVID results can provide recommendations to sup- Related article page 1881 COVID-19 and its associated port a clinically appropriate rationale for treatment timing. Such complications, including death. Unlike approaches that tri- a model could apply to other medical fields. Choosing to re- age cancer treatment using a tiered approach, Hartman et al ceive treatment now vs later is not a substantially different ben- have developed a web-based comprehensive model (Onc- efit or risk http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

To Treat or Not to Treat—Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic

JAMA Oncology , Volume 6 (12) – Dec 29, 2020

Loading next page...
 
/lp/american-medical-association/to-treat-or-not-to-treat-balancing-benefits-and-risks-of-treatment-lFWElxkO2v
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.4886
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL To Treat or Not to Treat—Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic Elizabeth Garrett-Mayer, PhD; Brian I. Rini, MD Decisions regarding the initiation of cancer therapy have be- a reluctant patient understand the increased risks of delaying come increasingly complex in the era of coronavirus disease treatment and, vice versa, the estimates may help another pa- 2019 (COVID-19). Health care professionals and patients must tient understand that the risks of cancer treatment delay are balance the benefits and risks of immediate treatment for can- minimal, and the patient can safely delay treatment until in- cer with the potential subse- fection levels in their region have decreased. In other words, quent increases in the risk of the OncCOVID results can provide recommendations to sup- Related article page 1881 COVID-19 and its associated port a clinically appropriate rationale for treatment timing. Such complications, including death. Unlike approaches that tri- a model could apply to other medical fields. Choosing to re- age cancer treatment using a tiered approach, Hartman et al ceive treatment now vs later is not a substantially different ben- have developed a web-based comprehensive model (Onc- efit or risk

Journal

JAMA OncologyAmerican Medical Association

Published: Dec 29, 2020

References